Epitope mapping immunodominant regions of the PilA protein of nontypeable Haemophilus influenzae (NTHI) to facilitate the design of two novel chimeric vaccine candidates

被引：51

作者：

Novotny, Laura A. ^{[1
,2
]}

Adams, Leanne D. ^{[1
,2
]}

Kang, D. Richard ^{[2
,3
]}

Wiet, Gregory J. ^{[2
,3
]}

Cai, Xueya ^{[4
,5
]}

Sethi, Sanjay ^{[4
,5
]}

Murphy, Timothy F. ^{[4
,5
]}

Bakaletz, Lauren O. ^{[1
,2
]}

机构：

[1] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA

[2] Ohio State Univ, Coll Med, Columbus, OH 43205 USA

[3] Nationwide Childrens Hosp, Dept Otolaryngol, Columbus, OH 43205 USA

[4] SUNY Buffalo, Buffalo, NY 14215 USA

[5] VA Western New York Healthcare Syst, Buffalo, NY 14215 USA

来源：

VACCINE | 2009年 / 28卷 / 01期

关键词：

Chinchilla; Otitis media; COPD; OUTER-MEMBRANE PROTEIN; OTITIS-PRONE CHILDREN; OBSTRUCTIVE PULMONARY-DISEASE; NASOPHARYNGEAL COLONIZATION; CHINCHILLA MODEL; MIDDLE-EAR; IV PILI; MORAXELLA-CATARRHALIS; P5-HOMOLOGOUS ADHESIN; PASSIVE-IMMUNIZATION;

D O I：

10.1016/j.vaccine.2009.08.017

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We designed and tested three PilA-derived vaccine candidates in a chinchilla model of ascending nontypeable Haemophilus influenzae (NTHI)-induced otitis media (OM) Delivery of antiserum directed against each immunogen conferred varying degrees of protection Presentation of a B-cell epitope derived from the OMP P5 adhesin at the N-terminus of recombinant soluble PilA protein (as opposed to the C-terminus), resulted in a protective chimeric immunogen that combined epitopes from two distinct NTHI adhesins (type IV pili and OMP P5) Incorporating protective epitopes derived from two NTHI adhesins/virulence determinants into a single pediatric vaccine candidate to prevent OM has multiple potential inherent advantages (C) 2009 Elsevier Ltd All rights reserved.

引用

页码：279 / 289

页数：11

共 47 条

[1] MODELING ADENOVIRUS TYPE-1-INDUCED OTITIS-MEDIA IN THE CHINCHILLA - EFFECT ON CILIARY ACTIVITY AND FLUID TRANSPORT FUNCTION OF EUSTACHIAN-TUBE MUCOSAL EPITHELIUM [J].

BAKALETZ, LO ;

DANIELS, RL ;

LIM, DJ .

JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (04) :865-872

[2] Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeable Haemophilus influenzae in the chinchilla [J].

Bakaletz, LO ;

Leake, ER ;

Billy, JM ;

Kaumaya, PTP .

VACCINE, 1997, 15 (09) :955-961

[3] Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection [J].

Bakaletz, LO ;

Kennedy, BJ ;

Novotny, LA ;

Duquesne, G ;

Cohen, J ;

Lobet, Y .

INFECTION AND IMMUNITY, 1999, 67 (06) :2746-2762

[4] Demonstration of type IV pilus expression and a twitching phenotype by Haemophilus influenzae [J].

Bakaletz, LO ;

Baker, BD ;

Jurcisek, JA ;

Harrison, A ;

Novotny, LA ;

Bookwalter, JE ;

Mungur, R ;

Munson, RS .

INFECTION AND IMMUNITY, 2005, 73 (03) :1635-1643

[5] Developing animal models for polymicrobial diseases [J].

Bakaletz, LO .

NATURE REVIEWS MICROBIOLOGY, 2004, 2 (07) :552-568

[6]

Bakaletz LO, 2002, POLYMICROBIAL DISEASES, P259

[7] Peptide and recombinant antigens for protection against bacterial middle ear infection [J].

Bakaletz, LO .

VACCINE, 2001, 19 (17-19) :2323-2328

[8] MICRO-ECOLOGY OF THE NASOPHARYNGEAL BACTERIAL-FLORA IN OTITIS-PRONE AND NON-OTITIS-PRONE CHILDREN [J].

BERNSTEIN, JM ;

FADEN, HF ;

DRYJA, DM ;

WACTAWSKIWENDE, J .

ACTA OTO-LARYNGOLOGICA, 1993, 113 (01) :88-92

[9] Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli [J].

Bieber, D ;

Ramer, SW ;

Wu, CY ;

Murray, WJ ;

Tobe, T ;

Fernandez, R ;

Schoolnik, GK .

SCIENCE, 1998, 280 (5372) :2114-2118

[10] EFFICACY TRIAL OF A PARENTERAL GONOCOCCAL PILUS VACCINE IN MEN [J].

BOSLEGO, JW ;

TRAMONT, EC ;

CHUNG, RC ;

MCCHESNEY, DG ;

CIAK, J ;

SADOFF, JC ;

PIZIAK, MV ;

BROWN, JD ;

BRINTON, CC ;

WOOD, SW ;

BRYAN, JR .

VACCINE, 1991, 9 (03) :154-162

← 1 2 3 4 5 →